Abiomed Inc (ABMD)

Add to Watchlists
Create an Alert
193.01 +0.95  +0.49% NASDAQ Aug 16, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/01/2019 08:00 EDT Misc Abiomed Inc Second Quarter Earnings Conference Call in 2020
11/01/2019 Earnings Abiomed Inc Second Quarter Earnings in 2020 Release
08/07/2019 08:00 EDT Misc Abiomed Inc Annual General Meeting in 2019
08/01/2019 08:00 EDT Misc Abiomed Inc First Quarter Earnings Conference Call in 2020
08/01/2019 Earnings Abiomed Inc First Quarter Earnings in 2020 Release
05/23/2019 Misc Abiomed Inc Annual Report in 2019
05/02/2019 08:00 EDT Misc Abiomed Inc Fourth Quarter Earnings Conference Call in 2019
05/02/2019 Earnings Abiomed Inc Fourth Quarter Earnings in 2019 Release
01/31/2019 08:00 EST Misc Abiomed Inc Third Quarter Earnings Conference Call in 2019
01/31/2019 Earnings Abiomed Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.abiomed.com
  • Investor Relations URL: http://investors.abiomed.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 01, 2019
  • Last Earnings Release: Aug. 01, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Top Fund Holders

Symbol Name Weighting
SLIM The Obesity ETF 4.27%
BCSIX Brown Capital Mgmt Small Co Inv 3.47%
POGRX PRIMECAP Odyssey Growth 3.21%
POAGX PRIMECAP Odyssey Aggressive Growth 2.95%
DBMCX BNY Mellon Sm/Md Cp Gr C 2.24%
CSMSX Carillon Scout Mid Cap R-5 1.42%
FSMRX Franklin Small-Mid Cap Growth R 1.17%
IHI iShares US Medical Devices ETF 0.98%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("ABMD","name")
  • Description: =YCI("ABMD","description")
  • Sector: =YCI("ABMD","sector")
  • Industry: =YCI("ABMD","industry")
  • Est. Current Fiscal Year End: =YCI("ABMD","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.